US Stock MarketDetailed Quotes

GOVX GeoVax Labs

Watchlist
  • 2.0000
  • +0.1500+8.11%
Close Mar 28 16:00 ET
  • 1.9300
  • -0.0700-3.50%
Post 19:56 ET
4.34MMarket Cap-139P/E (TTM)

About GeoVax Labs Company

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Company Profile

SymbolGOVX
Company NameGeoVax Labs
Listing Date09/25/2020
Founded1988
CEOMr. David A. Dodd
MarketNASDAQ
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1900 Lake Park Drive,Suite 380
CitySmyrna
ProvinceGeorgia
CountryUnited States of America
Zip Code30080
Phone1-678-384-7220

Company Executives

  • Name
  • Position
  • Salary
  • David A. Dodd
  • Chairman of the Board, Chief Executive Officer and President
  • 652.02K
  • Mark W. Reynolds, C.P.A.
  • Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
  • 421.40K
  • Dr. Mark J. Newman, PhD
  • Chief Scientific Officer
  • 437.37K
  • Dr. Kelly T. McKee, M.D.
  • Chief Medical Officer
  • --
  • Dr. John W. Sharkey, PhD
  • Vice President, Business Development
  • --
  • Dr. Randal D. Chase, PhD
  • Independent Director
  • 84.10K
  • Dean G. Kollintzas
  • Independent Director
  • 74.10K
  • John N. Spencer, Jr., C.P.A.
  • Independent Director
  • 81.60K
  • Dr. Robert T. McNally,PhD
  • Lead Independent Director
  • 84.10K
  • Nicole Lemerond
  • Independent Director
  • 47.43K
  • Dr. Jayne Morgan, M.D.
  • Independent Director
  • 38.64K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg